Several biomarkers have been proposed to distinguish the two diseases in early phase (8–12), and in particular, studies have showed that serum IL-18 could be used as a biomarker for differential diagnosis and AOSD disease evaluation (35). Here, IL18 is linked to adult-onset Still disease.